SNY & REGN’s Dupixent Gets EU Nod for Chronic Spontaneous Urticaria
Sanofi SNY and partner Regeneron REGN announced that the European Commission has approved Dupixent (dupilumab) for the treatment of…
‘I cannot describe this feeling’
Adam Kovalčík didn’t expect to win big when he flew from his small village in Slovakia to an…